These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Clinical observation on filiform-fire needling of "Biaoben acupoint combination" for 33 cases of sequelae of coronavirus disease 2019 during recovery period].
    Author: Luo ZH, Wang KX, Zhang YL, Chen ZQ, Chen B, Chen J, Zhou T, Gu XL, Li CL, Yan P, Tian LL, Xu CC, Chen BL, Chen S, Liang FX, Wu S.
    Journal: Zhongguo Zhen Jiu; 2022 Jul 12; 42(7):760-4. PubMed ID: 35793885.
    Abstract:
    OBJECTIVE: To observe the clinical therapeutic effect of filiform-fire needling of "Biaoben acupoint combination" on the sequelae of patients with coronavirus disease 2019 (COVID-19) during the recovery period. METHODS: A total of 33 patients with COVID-19 during the recovery period were treated with filiform-fire needling at the acupoints of Mingmen (GV 4), Shenzhu (GV 12), Gaohuang (BL 43), Zusanli (ST 36) and Shangjuxu (ST 37), etc., once every other day, 3 times a week, and 3 times was one course of treatment and totally 2 courses of treatment were required. The TCM symptom, Hamilton anxiety scale (HAMA) and Hamilton depression scale (HAMD) scores, pulmonary function indexes (forced vital capacity [FVC], forced expiratory volume in one second [FEV1], peak expiratory flow [PEF]) and chest CT imaging change were observed before and after treatment, and the therapeutic effect was evaluated. RESULTS: After treatment, the scores of TCM symptom, HAMA and HAMD were decreased compared with those before treatment (P<0.05), and the levels of FVC, FEV1 and PEF were increased compared with those before treatment (P<0.05), and the recovery rate of 22 patients with pulmonary ventilation dysfunction was 86.4% (19/22). After treatment, the lung shadow area was smaller than that before treatment (P<0.05). The effective rate of 25 patients with lung CT abnormalities was 84.0% (21/25). After treatment, 23 cases were cured, 5 cases were markedly effective, 4 cases were effective, 1 case was ineffective, the cured and markedly effective rate was 84.8%. CONCLUSION: The filiform-fire needling of "Biaoben acupoint combination" could significantly reduce the sequelae of cough, fatigue, chest tightness, etc. and mental symptoms such as anxiety and depression in patients with COVID-19 during the recovery period, and promote inflammatory exudation absorption of pulmonary lesion and improve lung ventilation function. 目的：观察“标本配穴”毫火针治疗新型冠状病毒肺炎恢复期患者后遗症状的临床疗效。方法：选取33例新型冠状病毒肺炎恢复期患者行毫火针治疗，穴取命门、身柱、膏肓、足三里、上巨虚等，隔天治疗1次，每周3次，3次为一疗程，共治疗2个疗程。观察患者治疗前后中医症状、汉密尔顿焦虑量表（HAMA）及汉密尔顿抑郁量表（HAMD）评分，肺功能指标[用力肺活量（FVC）、第1秒用力呼气容积（FEV1）、呼气峰值流速（PEF）]、胸部CT影像学变化情况，并评定临床疗效。结果：治疗后，患者中医症状评分及HAMA、HAMD评分均较治疗前降低（P<0.05）。治疗后患者FVC、FEV1、PEF均较治疗前升高（P<0.05），22例遗留有肺通气功能障碍患者恢复率为86.4%（19/22）。治疗后患者肺部阴影面积较治疗前缩小（P<0.05），25例遗留有肺部CT异常的患者有效率为84.0%（21/25）。治疗后痊愈23例，显效5例，有效4例，无效1例，愈显率为84.8%。结论：“标本配穴”毫火针能明显减轻新型冠状病毒肺炎恢复期患者咳嗽、乏力、胸闷等后遗症状以及焦虑抑郁等精神症状，同时促进肺部病灶炎性渗出吸收，改善肺通气功能。.
    [Abstract] [Full Text] [Related] [New Search]